Although this evidence suggests a potential tumor-suppressive role for SIRT7 in these cancers, rigorous experimental validation is still lacking, and the mechanisms underlying these putative effects remain to be addressed (Table 1; Figure 2). The gene discussed is SIRT7; the disease is neoplasm.